Identification of antimicrobial specialized metabolites from the human oral microbiome to target multidrug-resistant pathogens
从人类口腔微生物组中鉴定抗菌专门代谢物以靶向多重耐药病原体
基本信息
- 批准号:10605700
- 负责人:
- 金额:$ 3.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Aerodigestive TractAgeAnimalsAntibiotic ResistanceAntibioticsAutoimmune DiseasesBacteriaCaliberCardiovascular DiseasesClinicalClinical SkillsCommunicationDangerousnessDiseaseEnvironmentEvaluation StudiesFractionationGatekeepingGene ClusterGenomeGenomicsGenus staphylococcusGrowthHealthHumanHuman MicrobiomeInfectionIntegration Host FactorsInvadedLaboratoriesLeadLifeLower Gastrointestinal TractMediatingMedicalMentorshipMetadataMetagenomicsMicrobeMicrobiologyMulti-Drug ResistanceMultiple Bacterial Drug ResistanceNatural ProductsNoseOralOral cavityParticipantPathogenicityPeptidesPeriodicityPharmaceutical PreparationsPhysiciansPlayPopulation HeterogeneityPredispositionPreventionPrevotellaProceduresProductionResearchResearch TrainingResourcesRespiratory SystemRibosomesRisk FactorsRoleSalivarySamplingScientistShapesShotgunsSiteSourceStreptococcusStructureSwabTestingTherapeutic immunosuppressionUnited StatesUniversitiesVancomycin resistant enterococcusWarWisconsinWorkantibiotic resistant infectionsantimicrobialantimicrobial drugbactericidecareercolonization resistancecomparativedrug developmentdrug resistant microorganismdrug resistant pathogendysbiosisefficacy testingfecal microbiomehealth determinantshuman microbiotaimmunoregulationin vivoinsightmetabolomicsmetagenomemetagenomic sequencingmicrobial communitymicrobiomemicrobiotamicroorganismmulti-drug resistant pathogenoral microbial communityoral microbiomeoral streptococcipathogenpolyketidespreventreference genomesafety testingscreeningsmall moleculesocioenvironmental factorurban setting
项目摘要
PROJECT SUMMARY / ABSTRACT
Our microbiome plays a key role in colonization resistance, which is the prevention of growth, persistence, and
subsequent infection by pathogenic microorganisms. Disruptions in an established microbial community and its
functioning can alter infection susceptibility. Understanding how changes in the oral microbiome render it
vulnerable to pathogen colonization is essential, as carriage of drug-resistant microbes is a major risk factor for
developing serious and difficult-to-treat infections. One mechanism by which our microbiome acts to prevent
pathogen colonization is through the production of antimicrobial specialized metabolites (ASMs) that directly
inhibit the growth of competing microbes. Identification of such bioactive metabolites can be facilitated by
examining the biosynthetic gene clusters (BGC) that encode them. Analysis of reference genomes generated
through the Human Microbiome Project identified 3,118 BGCs across various body sites, with the typical oral
cavity containing high BGC abundance (1,061+/-143 clusters). The microbiota inhabiting this site represent a
first point of contact with the environment and invading microbes, and therefore, play a vital gatekeeping role
against pathogen dissemination to the lower gastrointestinal and respiratory tracts. Yet, the structure and
function of ASMs produced by human-associated microbiota remains limited, particularly within the oral cavity.
This proposal seeks to leverage a combination of comparative metagenomic and metabolomic approaches to
determine the role of ASM production by oral-associated bacteria in defense against multidrug-resistant
organisms (MDRO). The specific aims are to 1) define differences in oral microbiomes between MDRO
carriers versus non-carriers and assess how determinants of health associate with abundance of key
taxa, and 2) evaluate the production of bioactive ASMs by oral-associated bacteria from MDRO carriers
versus non-carriers. These objectives will be accomplished through shotgun metagenomic sequencing of oral
microbiome samples from diverse populations, paired with analysis of detailed associated metadata relating to
health and MDRO carriage risk factors. Identification of antimicrobial metabolite producing bacteria will be
achieved through high-throughput bioactivity-guided fractionation, followed by metabolomic analysis and in vivo
efficacy testing. The study of ASM production by oral microbiota will yield insight into the factors shaping this
dynamic microbial community and serve as an untapped source for much-needed, new antimicrobial drug leads.
The unmatched caliber of microbiology research performed at the University of Wisconsin-Madison will provide
an ideal environment to carry out the proposed work. Resources and mentorship provided by project sponsor
Dr. Cameron Currie and collaborators will facilitate the timely completion of this proposal. Moreover, execution
of this tailored research training plan will enable the applicant to develop the necessary experimental,
communication, and clinical skills for a successful transition to a career as a physician-scientist.
项目摘要/摘要
我们的微生物群在抵抗定居方面起着关键作用,这是防止生长、持久性和
随后被病原微生物感染。已建立的微生物群落的破坏及其
功能可以改变感染的易感性。了解口腔微生物群的变化是如何导致它的
易受病原体定植是必不可少的,因为携带耐药微生物是
出现严重和难以治疗的感染。我们的微生物群通过一种机制来防止
病原体定植是通过产生抗微生物的专门代谢物(ASM)直接
抑制相互竞争的微生物的生长。这样的生物活性代谢物的鉴定可以通过
检查编码它们的生物合成基因簇(BGC)。产生的参考基因组的分析
通过人类微生物组计划,在不同的身体部位发现了3118个BGC,典型的口腔
包含高BGC丰度(1,061+/-143团)的空腔。栖息在该地点的微生物区系代表着
与环境和入侵微生物的第一个接触点,因此发挥着至关重要的把关作用
防止病原体扩散到下消化道和呼吸道。然而,它的结构和
人类相关微生物群产生的ASM的功能仍然有限,特别是在口腔内。
这项建议寻求利用比较元基因组学和代谢组学方法的组合来
确定口腔相关细菌产生ASM在防御多重耐药中的作用
有机体(MDRO)。具体目的是:1)确定MDRO和MDRO在口腔微生物区系上的差异
携带者与非携带者,并评估健康决定因素如何与大量关键因素相关联
2)评估MDRO携带者口腔相关细菌产生生物活性ASM的情况
与非携带者相比。这些目标将通过口腔的元基因组测序来实现
来自不同人群的微生物组样本,以及与以下相关的详细相关元数据的分析
健康和MDRO运输风险因素。将对产生抗微生物代谢产物的细菌进行鉴定
通过高通量生物活性引导分级,然后进行代谢组学分析和体内
药效测试。对口腔微生物群产生ASM的研究将有助于深入了解影响这一现象的因素
具有活力的微生物群落,并作为急需的新抗菌药物线索的未开发来源。
威斯康星大学麦迪逊分校进行的无与伦比的微生物学研究将提供
开展拟议工作的理想环境。项目发起人提供的资源和指导
卡梅隆·柯里博士和合作者将为及时完成这项提案提供便利。此外,执行
这一量身定制的研究培训计划将使申请者能够开发必要的实验,
沟通,以及成功过渡到医生-科学家职业生涯的临床技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN ZELASKO其他文献
SUSAN ZELASKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 3.86万 - 项目类别:
Research Grant